Baylor College of Medicine, based in Houston, is the only private medical school in the Greater Southwest, is recognized as a premier academic health science center and is known for excellence in education, research and patient care. For 2014, U.S. News & World Reportranked BCM as one of the top 20 medical schools for research. Located in the Texas Medical Center, Baylor College of Medicine has affiliations with eight teaching hospitals, each known for medical excellence. Read more about our affiliates.
The college has total research support of $363 million, with $280 million from federal sources, and more than 90 research and patient-care centers and units. Currently, BCM trains more than 3,000 medical, graduate, nurse anesthesia, and physician assistant students, as well as residents and post-doctoral fellows. Baylor College of Medicine is committed to being a national leader in advancing human health through the integration of patient care, research, education, and community service.
www.seqwright.com (A GE company.)
SeqWright, Inc. is a full-service Next Generation Sequencing (NGS) service provider and research organization. SeqWright is both CLIA certified and GLP compliant, enabling the company to offer services in support of product regulatory submissions. With over 17 years of genomics experience, SeqWright has built a reputation for quality, technical expertise and a willingness to customize services to meet its customers' individual needs. The company’s mission is to drive scientific and medical innovation by helping to facilitate and accelerate the research and development efforts of its customers. Founded in 1994 by John W. Belmont, M.D., Ph.D. and Richard Gibbs, Ph.D., Director of the Human Genome Sequencing Center, SeqWright was acquired by Clarient Diagnostic Services, Inc., a GE Healthcare Company in 2012.
Diagnomics Inc., is a San Diego based genomics and bioinformatics company providing solutions for personalized medicine and next generation healthcare. Diagnomics is one of the first Next Generation Sequencing (NGS)-based genomics companies on the West Coast of the U.S., and is made up of a highly qualified team of scientists and researchers including early pioneers in the sequencing of human genomes.
Diagnomics has some of the most advanced bioinformatics software available today to analyze and annotate NGS genomic findings. In addition, the company provides services for genome discovery, has the necessary medical expertise to guide discovery of new therapeutic targets, and has novel diagnostic tools that will lead to safer and more effective treatment of patients.
The Co-Founder of Diagnomics, Dr. Stefan Gruenwald, M.D., PhD., is one of DNA-SEQ’s key strategic partners as a Co-Founder, Chariman of the Scientific Advisory Board and non-voting member of the Board of Directors of the DNA-SEQ Alliance. His long career in life sciences includes being the VP of R&D of PharMingen (now a part of BD Bioscience) where his R&D lab cloned over 1,300 genes and expressed more than 200 proteins in various protein expression systems. Dr. Gruenwald then went on to co-found Orbigen, a San Diego-based proteomics company. Orbigen developed over 3,000 products in a dozen different areas ranging from proteomics to immunology. In 2004, Dr. Gruenwald was crucial in negotiating the merger between Orbigen and Jingmei, the second largest Biotech reagent company in China.
The San Diego Supercomputer Center (SDSC) is an organized research unit of the University of California, San Diego (UCSD). Founded in 1985, its self-prescribed mission is "developing and using technology to advance science". SDSC is primarily funded by the National Science Foundation (NSF) and pursues research in the areas of high performance computing, grid computing, computational biology, geoinformatics, computational physics, computational chemistry, data management, scientific visualization, and computer networking. SDSC is internationally recognized for its contribution to computational biosciences and computational approaches to earth sciences and genomics.
SDSC is home to the Performance Modeling and Characterization (PMaC) laboratory, whose mission is to bring scientific rigor to the prediction and understanding of factors affecting the performance of current and projected High Performance Computing (HPC) platforms. PMaC is funded by the Department of Energy (SciDac PERC research grant), the Department of Defense (Navy DSRC PET program), DARPA, and the National Science Foundation.
Xtal BioStructures, Inc. (XTAL) is a contract research organization (CRO) founded in 2005 with the mission of providing early stage drug discovery research services to the pharmaceutical and biotechnology industries through high quality research services and reagents. To enable proof-of-concept experiments and drug discovery programs, XTAL produces high-purity biochemical products, provides a pipeline of affinity-based biophysical measurements, and generates high-resolution X-ray crystal structures. XTAL's research focus is to gaining insights and understanding of proteins and their interactions with ligands, other macromolecules, or drug candidates. With a collaborative outlook, XTAL “stays close to the science" by critically evaluating relevant project literature and applying their expertise and experience to both the project design and execution.
D-Wave Systems, Inc. is a quantum computing company, based in Burnaby, British Columbia. D-Wave is in the development of a new class of high performance computing systems. These systems are architected around a processor that uses a computational model known as adiabatic quantum computing (AQC). These processors are fabricated using superconducting metals instead of semiconductors and are operated at ultra-low temperatures in a magnetic vacuum. They are designed explicitly to harness quantum mechanical effects to fundamentally and dramatically reduce the time and memory requirements for computation.
In May 2011, D-Wave System announced D-Wave One, the world's first commercially available quantum computer with Lockheed Marin being their first customer. In May 2013 it announced that a collaboration between NASA, Google and the Universities Space Research Association (USRA) launched a Quantum Artificial Intelligence Lab using a 512 qubit D-Wave Two that would be used for research into machine learning, among other fields of study.